1264812

Tulex Pharmaceuticals Inc. — FEI 3011875665

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 24, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cranbury, NJ (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures
360321 CFR 211.160(b)Scientifically sound laboratory controls